Trial Profile
Phase I Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of BAT1306 in Patients With Advanced or Metastatic Solid Tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs BAT-1306 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 04 Jan 2018 New trial record